←
Andreas Mock56 posts
Andreas Mock avatar

Andreas Mock

@am0ck

MD/PhD - 🔬Pathologist & Max-Eder Research Group Leader in Clinical Multi-Omics

◷ Joined July 2016▧ 5 Photos and videos
Rushin Gindra avatar
⟳ Andreas Mock retweeted
Rushin Gindra@rushin_gindra·May 5

1/7🎉 Introducing Phoenix: generative AI predicting spatially resolved gene expression from routine H&E slides-enabling virtual spatial-omics. Zero-shot. Across cancers, organs & species. Huge thanks to my co-first @TranManuel & all collaborators! 🙌 📜: doi.org/10.64898/2026.04.25.…

Post attachment
NCT Heidelberg avatar
⟳ Andreas Mock retweeted
NCT Heidelberg@NCT_HD·27 Oct 2023

Neue Publikation des DKFZ/NCT/DKTK MASTER-Programm: Handbuch zur Nutzung von Genomdaten i. d. Präzisionsonkologie. Handbuch soll Ärzt:innen, Biolog:innen und Bioinformatiker:innen bei der klinischen Interpretation genomweiter molekularer Informationen unterstützen.

Post attachment
Andreas Mock avatar
Andreas Mock@am0ck·26 Oct 2023

Clinical Multiomics for #PrecisionOncology - It’s exciting to reflect about its utility today and the prospect it holds. Let’s bring it to even more patients in the near future!

Please read our new paper, published today with @SpringerNature in @Nature_NPJ, on the practical approach at @NCT_HD and @NCT_UCC_DD to clinical decision-making in molecular tumor boards based on genome/exome, transcriptome, and methylome data: rdcu.be/dpwCy

Anna Dysko avatar
⟳ Andreas Mock retweeted
Anna Dysko@PBannanna·14 Feb 2023

Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing Great study from ⁦@DKFZ⁩ ⁦@am0ck⁩ on shallow #nanopore RNA sequencing for transcriptome profiling of human cancers. ⁦@SciReports⁩ #cancer nature.com/articles/s41598-0…

Cihan Erkut avatar
⟳ Andreas Mock retweeted
Cihan Erkut@erkutcihank·1 Jun 2022

Our latest work is now online as a preprint in #bioRxiv. I had the honor to work with @am0ck, Melissa Braun, @claudia_scholl and @StefanFrohling at @DKFZ and @NCT_HD. We used Oxford @nanopore sequencing to get a glimpse of the transcriptomes of tumor samples, which were 1/8

Shallow nanopore RNA sequencing enables transcriptome profiling for precision cancer medicine biorxiv.org/cgi/content/shor… #bioRxiv

Andreas Mock avatar
Andreas Mock@am0ck·24 Aug 2021

Fantastic #PrecisionMedicine effort by @mpmnedumudy and @Elkabetslab for patients with #headandneckcancer. Perfect example that we need to better understand the impact of targeted therapies on the tumor immune microenvironment.

@mpmnedumudy showed that the #MAPK pathway is hyperactive in #headandneckcancer (HNC) and is associate with poor prognosis (collaboration Hess @am0ck @DKFZ @HeidelbergU. Treatment of mice with trametinib, an MEK1/2 inhibitor, induced a delay in HNC initiation and progression.

Post attachment
Stefan Fröhling avatar
⟳ Andreas Mock retweeted
Stefan Fröhling@StefanFrohling·4 Aug 2021

Wir freuen uns, dass das @Dt_Aerzteblatt auf unsere Arbeit aufmerksam macht, die hoffentlich dazu beiträgt, seltene Krebserkrankungen besser zu verstehen, präziser zu diagnostizieren und wirksamer zu behandeln. @NCT_HD @DKFZ @DKTK_ @uniklinik_hd

Patienten mit seltenen Krebserkrankungen profitieren von molekularer Analyse: Heidelberg – Patienten mit seltenen Tumorerkrankungen profitieren von einer umfassenden molekularen Analyse des… dlvr.it/S4yMbg #Studie #selteneKrebserkrankungen #Analyse #NCT #DKFZ

Post attachment
Stefan Fröhling avatar
⟳ Andreas Mock retweeted
Stefan Fröhling@StefanFrohling·13 Jun 2021

We are excited to see this work published and hope it will help improve our understanding and clinical management of #RareCancers such as bone and soft-tissue #Sarcoma. Please get in touch if you are interested in collaborating with us!

Online now in @CD_AACR: Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with #RareCancers (from the @DKTK_ MASTER Program) @StefanFrohling @DKFZ @NCT_HD @TMO_Heidelberg @uniklinik_hd @NCT_UCC_DD cancerdiscovery.aacrjournals…